INMB

INMB

USD

INmune Bio Inc. Common stock

$1.720-0.050 (-2.825%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$1.770

Máximo

$1.790

Mínimo

$1.710

Volume

0.26M

Fundamentos da empresa

Capitalização de mercado

45.7M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.61M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.71Atual $1.720Máximo $11.64

Notícias relacionadas

GlobeNewswire

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate

Ver mais
GlobeNewswire

INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025

Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, Oct. 23, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), INmune Bio Inc. (NASDAQ:INMB), a

Ver mais
GlobeNewswire

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a

Ver mais
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025